Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software

IT & Software

JHL Biotech selects PaizaBio to provide fill-finish services for multiple projects PaizaBio has secured an agreement with Taiwan-based JHL Biotech to provide fill-finish services for multiple JHL projects.
Automation > IT & Software > News
Bayer, ERS Genomics sign licensing deal for genome editing patents Bayer and ERS have signed a patent license agreement whereby Bayer gains access to ERS' CRISPR-Cas9 genome-editing patents for certain cross-divisional applications in Bayer's core strategic areas.
Automation > IT & Software > News IBM Research and Singapore’s Bioengineering Institute develop anti-viral technology By PBR Staff Writer
IBM Research and Singapore’s Institute of Bioengineering and Nanotechnology have discovered a new macromolecule with triple-play action to help fight virus infection and drug resistance.
Automation > IT & Software > News
See more IT & Software news

Latest IT & Software News and Insight

View all IT & Software news or find news targeted to your interests
UCLA scientists use gene-editing technology for faster antiviral drug development
In an advance that could lead to the development of better treatments for viral pathogens, such as Zika, a team of scientists at the California NanoSystems Institute at UCLA are developing a more accurate and more cost-effective DNA-screening system based on gene-editing technology.
Automation > IT & Software > News
IBC Generium selects Goodwin Biotechnology to optimize process of IgG-based bispecific antibody
International Biotechnology Center "Generium", (LLC IBC Generium), has selected Goodwin Biotechnology for the assay and process technology transfer, process scale-up, and cGMP manufacturing of an IgG-based, bispecific antibody to support early stage clinical trials.
Automation > IT & Software > News
biOasis Technologies signs license deal with Astellas Research Institute of America
biOasis Technologies has entered into a License Agreement to collaborate with Astellas Research Institute of America (Astellas).
Automation > IT & Software > News
Bristol-Myers Squibb selects Medidata Clinical Cloud to help manage clinical trials
Bristol-Myers Squibb has selected the Medidata Clinical Cloud to help manage, monitor and analyze its clinical trials.
Automation > IT & Software > News
Halo Pharmaceutical, ExxPharma partner to develop products using Twin Screw Extrusion technology
ExxPharma Therapeutics and Halo Pharmaceutical have entered into a collaboration agreement to develop and manufacture drug products for customers of Halo and ExxPharma using ExxPharma's innovative drug delivery systems and twin screw extrusion-based manufacturing technology.
Automation > IT & Software > News
GlaxoSmithKline selects TierPoint to support global data consolidation and protection initiatives
GlaxoSmithKline (GSK) has selected TierPoint to support its global data consolidation and protection initiatives.
Automation > IT & Software > News
Oracle offers cloud solution to help enhance drug safety
By PBR Staff Writer
Technology firm Oracle is offering a complete cloud solution to help pharma companies improve drug safety.
Automation > IT & Software > News
Supernus Pharmaceuticals selects DSG to support two ADHD phase 3 clinical studies
By PBR Staff Writer
Supernus Pharmaceuticals has selected electronic data capture (EDC) clinical trial software provider DSG to support two phase 3 clinical studies on impulsive aggression in pediatric patients being treated for attention deficit/hyperactivity disorder (ADHD).
Automation > IT & Software > News
Eisai signs three-year contract extension for CSC's Total Regulatory Solutions as-a-Service
Drug maker Eisai has signed a three-year contract extension for CSC's Total Regulatory Solutions (TRS) as-a-Service.
Automation > IT & Software > News
Marina Biotech inks license deal to deliver genome editing technology
Marina Biotech has signed a license agreement covering the company's SMARTICLES and DiLA2 platforms for the delivery of an undisclosed genome editing technology.
Automation > IT & Software > News
View all IT & Software news or find news targeted to your interests